For the quarter, Voya MidCap Opportunities Strategy underperformed the Index on a NAV basis due to both allocation effects ...

Weyco (WEYS) stock's 2Q25 earnings reveal revenue and margin struggles across brands. See more on key challenges, tariff ...

The S&P 500 dipped 0.3% after flirting with its all-time high, which was set two weeks ago, earlier in the day. The Dow Jones ...

Indian equities saw gains as retail inflation hit an 8-year low, boosting domestic sentiment despite global geopolitical tensions. Analysts anticipate range-bound market activity, favoring domestic ...

Is Apple falling behind, or will it come from behind? The post Nvidia and Microsoft stocks have reached a $4 trillion ...

The Oncology Institute (NASDAQ:TOI) reported fiscal second quarter ended June 30, 2025, earnings on August 13, 2025, posting 21.5% year-over-year revenue growth to $119.8 million. Pharmacy revenue ...

Key Points Jasper Therapeutics (NASDAQ:JSPR) reported a GAAP loss per share of $1.74 for Q2 2025. Research and development expenses (GAAP) nearly doubled to $21.2 million in Q2 2025 from $11.3 million ...

Cellebrite (CLBT) boasts strong growth potential with robust financials, digital forensics leadership, and a durable moat.

Key Points GAAP earnings per share of $0.04 exceeded the consensus estimate of negative $0.08 for Q2 2025 No commercial revenue reported; company remains in pre-revenue phase with product launches ...

U.S. stocks are ticking higher after a rally spurred by hopes for lower U.S. interest rates wrapped around the world. The S&P 500 rose 0.2% Wednesday, coming off its latest all-time high. The Dow ...

Key Points Spectral Ai completed its De Novo application submission to the FDA for the DeepView System in June 2025, marking a major regulatory milestone. Revenue for the quarter declined 32.0% year ...

U.S. stocks are drifting around their record levels after a rally spurred by hopes for lower U.S. interest rates wrapped around the world. The S&P 500 rose 0.1% Wednesday, coming off its latest ...